Why are researchers going beyond mutations to study cancer?
Cancer is an incredibly complex system, and researchers in Toronto have found that mutations alone…
Browsing: Press Release
Celsius Therapeutics Announces Initiation of Dosing in Phase 1 Clinical Trial of CEL383, an Anti-TREM1 Antibody for the Treatment of Inflammatory Bowel Disease
Celsius Therapeutics, a biotechnology company pioneering new precision medicines for patients with inflammatory disease by…
Single-nuclei RNA sequencing detects gene splicing defect known as “cryptic exons” in ALS
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating neurodegenerative diseases with mean survival…
GeneCentric Therapeutics announces publication of new results showing clinical benefit of RNA-based Antifolate Predictive Response Signature (AF-PRS) to guide lung cancer treatment selection
The Piedmont Study, a Real-World Data Analysis in Patients Treated with Platinum Doublet Chemotherapy and/or…
Hummingbird Diagnostics announces publication of miLung small RNA-based blood test data for early detection of lung cancer
Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and…
Tempus launches standalone RNA sequencing test, xR
Tempus, a leader in artificial intelligence and precision medicine, introduces its standalone RNA next-generation sequencing assay, Tempus…
RealSeq Biosciences launches novel small RNA-seq technology
RealSeq Biosciences has developed a targeted removal probe (Selective Suppression Probe- SSP) approach to deplete undesired…
MGI Partners with Xpress Genomics to Advance Deep Single-cell RNA-Sequencing Technologies
MGI, a company committed to building core tools and technology to lead life science, announced…
Twist Bioscience launches portfolio of RNA sequencing tools
Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA…
Immunai’s state-of-the-art single-cell RNA sequencing technology informs the development of more effective cancer immunotherapy
Investigators from Baylor College of Medicine (BCM) in collaboration with Immunai have published results from a clinical…